共 11 条
[1]
[Anonymous], 2012, GUID CLIN INV MED PR
[2]
EMA must improve the quality of its clinical trial reports
[J].
BMJ-BRITISH MEDICAL JOURNAL,
2011, 342
[4]
All trials must be registered and the results published
[J].
BMJ-BRITISH MEDICAL JOURNAL,
2013, 346
[5]
Patients and the public deserve big changes in evaluation of drugs
[J].
BRITISH MEDICAL JOURNAL,
2009, 338
[8]
How to Use a Noninferiority Trial Users' Guides to the Medical Literature
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2012, 308 (24)
:2605-2611
[9]
Building Comparative Efficacy and Tolerability Into the FDA Approval Process
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2010, 303 (10)
:979-980
[10]
A Lifecycle Approach to the Evaluation of FDA Approval Methods and Regulatory Actions Opportunities Provided by a New IOM Report
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2012, 307 (23)
:2491-2492